Dr. Martens appoints Giles Wilson as CFO
Wilson qualified as a chartered accountant with PwC and previously held a senior role at Commercial Estates Group
Register to get 1 more free article
Reveal the article below by registering for our email newsletter.
Want unlimited access? View Plans
Already have an account? Sign in
Dr. Martens plc has announced that Giles Wilson has been appointed to the role of chief financial officer (CFO).
Wilson will join Dr. Martens and take up his role in 2024, with the date to be confirmed and announced in due course.
Wilson is an experienced CFO who joins Dr. Martens from William Grant and Sons Limited, the global spirits company, owner of brands including Glenfiddich Scotch Whisky, The Balvenie Whisky and Hendrick’s Gin.
Prior to this, he was at John Menzies plc as CFO (2016-20), and then subsequently became CEO (2019-20). Wilson qualified as a chartered accountant with PwC and previously held a senior role at Commercial Estates Group.
Chair Paul Mason said: “Following a rigorous selection process, we are delighted to appoint Giles as CFO. He is a very capable finance leader with extensive experience in a number of sectors, and, most recently, his time in the branded spirits industry has given him a good grounding in global brands and wholesale distribution management.
“His knowledge of the public markets will be a valuable asset to the team as Dr. Martens continues its growth in the listed environment. I look forward to him joining the board.”
Kenny Wilson, CEO, added: “I am thrilled that Giles will be joining the leadership team and the Board. He brings a range of complementary skills and past experience that is highly relevant to our brand-first strategy. I am looking forward to working with him on the next phase of Dr. Martens’ journey to become a £2bn revenue footwear brand.”
Wilson concluded: “Dr. Martens is an iconic brand I have long admired, and I have been impressed by the passion and ambition within the business. I am excited to be joining at such an important stage in the Company’s growth and I am looking forward to working with Kenny and the team to drive the strategy forward.”
Dr. Martens added that Jon Mortimore, who is retiring from the company as previously announced, has agreed to stay with the business until the end of the financial year.
